ARCHIVES

Zevalin Regimen Effective In Mantle Cell Lymphoma

This article is from The Cancer Letter archive.

Vol. 27 No. 1 | January 30, 2004

Download PDF Visit The Full Archive

Related Articles

Funding opportunities listed.

April 16, 2004

Celebrex Studied As Potential Prevention Of Lung Cancer In High-Risk Populations

August 31, 2001

ODAC Recommends Femara Campath For FDA Approval.

January 5, 2001

In Brief: Bresnick Directs Norris Cotton Cancer Center; FASEB Honors Kirschstein; Van Nevel’s 2th Year

February 5, 1993

Nutrition RFPs Will Really Be Grants, Gori Says

January 23, 1976

Adding Topotecan To Standard Treatment Doesn’t Improve Progression-Free Survival

October 29, 2010